10-K/A

AMENDMENT NO. 1 TO FORM 10-K

Company: Jazz Pharmaceuticals plc
Filed: April 28, 2014
Period of Report: December 31, 2013
Accession Number: 0001232524-14-000041

View Document ↗ View on SEC.gov ↗